(Q33712400)

28 July 2017

title

Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer (English)

1 reference

28 July 2017

1 reference

Da-zhi Xu

1

1 reference

28 July 2017

Qi-rong Geng

2

1 reference

28 July 2017

Ying Tian

3

1 reference

28 July 2017

Mu-yan Cai

4

1 reference

28 July 2017

Xin-juan Fang

5

1 reference

28 July 2017

You-qing Zhan

6

1 reference

28 July 2017

Zhi-wei Zhou

7

1 reference

28 July 2017

Wei Li

8

1 reference

28 July 2017

Ying-bo Chen

9

1 reference

28 July 2017

Xiao-wei Sun

10

1 reference

28 July 2017

Yuan-xiang Guan

11

1 reference

28 July 2017

Yuan-fang Li

12

1 reference

28 July 2017

Tong-yu Lin

13

1 reference

28 July 2017

language of work or name

English

0 references

publication date

7 October 2010

1 reference

28 July 2017

1 reference

28 July 2017

volume

10

1 reference

28 July 2017

page(s)

536

1 reference

POT1 deficiency alters telomere length and telomere-associated gene expression in human gastric cancer cells

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958947

mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958947

Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958947

Everolimus (RAD001) and anti-angiogenic cyclophosphamide show long-term control of gastric cancer growth in vivo

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958947

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958947

Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958947

An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958947

Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958947

Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958947

Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958947

Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958947

mTOR and cancer: insights into a complex relationship

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958947

21 June 2018

Cancer statistics, 2006

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958947

TOR signaling in growth and metabolism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958947

Gastric adenocarcinoma: review and considerations for future directions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958947

Meta-analysis of intraperitoneal chemotherapy for gastric cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958947

Recent results in understanding molecular pathways in the medical treatment of esophageal and gastric cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958947

A mammalian protein targeted by G1-arresting rapamycin-receptor complex

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958947

mTOR and P70 S6 kinase expression in primary liver neoplasms

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-536

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-536

The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-536

Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-536

Relation between outcomes and localisation of p-mTOR expression in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-536

p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate

21 January 2018

1 reference

12 December 2020

Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome

1 reference

12 December 2020

Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery

1 reference

12 December 2020

Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients

1 reference

12 December 2020

D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer

1 reference

12 December 2020

Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes

1 reference

12 December 2020

Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer

1 reference

12 December 2020

1 reference

12 December 2020

Predictive and prognostic role of activated mammalian target of rapamycin in cervical cancer treated with cisplatin-based neoadjuvant chemotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-10-536

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference